Shanghai Haohai Biological Technology Co., Ltd.
6826.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.48B
Close$
Share Statistics
| Market cap | $6.48 Billion |
|---|---|
| Enterprise Value | $4.68 Billion |
| Dividend Yield | $1.13 (2.76%) |
| Earnings per Share | $1.08 |
| Beta | 0.47 |
| Outstanding Shares | 224,750,100 |
Return
| Return on Equity | 2.88% |
|---|---|
| Return on Assets | 2.33% |
| Return on Invested Capital | 1.51% |
Valuation & Multiples
| P/E Ratio | 45.93 |
|---|---|
| PEG | -67.89 |
| Price to Sales | 1.6 |
| Price to Book Ratio | 0.67 |
| Enterprise Value to Revenue | 1.99 |
| Enterprise Value to EBIT | 55.46 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 21, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 23, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shanghai Haohai Biological Technology Co., Ltd.
1,999 employees
CEO: Wu Jianying Shanghai Haohai Biological Technology Co., Ltd. is a global enterprise dedicated to the research, development, manufacturing, and commercialization of biomedical materials. Its operations span Mainland China, the United States, the Unite...